Current reports

Up-to-date announcements resulting from information obligations of listed companies.

Current reports published before January 1, 2024 are available on the Polish section:

Report Details Publication Action
2025 ESPI Report 27/2025

Information on the conclusion of a significant sales agreement

17.04.2025 Read more
2025 ESPI Report 26/2025

Notification of transactions on the Company's shares

14.04.2025 Read more
2025 ESPI Report 25/2025

Operational highlights of the medical devices, IT solutions and services sales segment

11.04.2025 Read more
2025 ESPI Report 24/2025

Information on the conclusion of a significant agreement on the sale of a robotic system

10.04.2025 da-vinci-en,sale-agreements Read more
2025 ESPI Report 23/2025 Adoption of directional resolution on division of the Company 27.03.2025 cardiotracer,other-issues Read more
2025 ESPI Report 22/2025

Notification of transactions on the Company's shares

10.03.2025 other-issues Read more
2025 ESPI Report 21/2025

Information on the conclusion of a significant sales agreement

28.02.2025 da-vinci-en,sale-agreements Read more
2025 ESPI Report 20/2025

Receipt of a notice under the procedure envisaged by art. 69 of the Act on Offerings - change in the percentage of the total number of votes in the Company

27.02.2025 other-issues Read more
2025 ESPI Report 19/2025

Receipt of a notice under the procedure envisaged by art. 69 of the Act on Offerings - change in the percentage of the total number of votes in the Company

27.02.2025 other-issues Read more
2025 ESPI Report 18/2025

Notification of transactions executed by a person discharging managerial responsibilities

21.02.2025 other-issues Read more
2025 ESPI Report 17/2025 with correction

Notification of transactions executed by a person discharging managerial responsibilities

21.02.2025 other-issues Read more
2025 ESPI Report 16/2025

Information on the completion of the book-building process for Synektik SA shares

19.02.2025 other-issues Read more
2025 ESPI Report 15/2025

Information on the commencement of the book-building process for Synektik SA shares

19.02.2025 other-issues Read more
2025 ESPI Report 14/2025

Information on the conclusion of a significant agreement on the sale of a robotic system

18.02.2025 da-vinci-en,sale-agreements Read more
2025 ESPI Report 13/2025

Estimated revenue in Q1/ FY 2024

24.01.2025 other-issues Read more
2025 ESPI Report 12/2025

List of shareholders holding at least 5% of the total number of votes at the Ordinary Shareholder Meeting on 22 January 2025

23.01.2025 shareholder-meetings Read more
2025 ESPI Report 11/2025

Constitution of the Company’s Supervisory Board

22.01.2025 shareholder-meetings Read more
2025 ESPI Report 10/2025

Resolutions adopted by the Ordinary Shareholder Meeting of Synektik SA on 22 January 2025

22.01.2025 shareholder-meetings Read more
2025 ESPI Report 9/2025

Appointment of Supervisory Board Members

22.01.2025 shareholder-meetings Read more
2025 ESPI Report 8/2025

Dividend payout resolution

22.01.2025 dividend,shareholder-meetings Read more
2025 ESPI Report 7/2025

Additional documentation for the Ordinary Shareholder Meeting of SYNEKTIK SA

20.01.2025 shareholder-meetings Read more
2025 ESPI Report 6/2025

Declaration on not exercising the personal right to appoint Supervisory Board members

20.01.2025 shareholder-meetings Read more
2025 ESPI Report 5/2025

Submission of candidates to the Issuer’s Supervisory Board

16.01.2025 shareholder-meetings Read more
2025 ESPI Report 4/2025

Information on the conclusion of a significant agreement on the sale of a robotic system

15.01.2025 da-vinci-en,sale-agreements Read more
2025 ESPI Report 3/2025

Acquisition of shares in a company holding medical IT software

14.01.2025 other-issues Read more
2025 ESPI Report 2/2025

Operational highlights of the medical devices, IT solutions and services sales segment

13.01.2025 other-issues Read more
2025 ESPI Report 1/2025

Information on the conclusion of a significant agreement on the sale of a robotic system

09.01.2025 da-vinci-en,sale-agreements Read more
2024 ESPI Report 66/2024

Notification of transactions on the Company's shares

30.12.2024 other-issues Read more
2024 ESPI Report 65/2024

Announcement on Convening the Ordinary Shareholder Meeting to be held on 22 January 2025

23.12.2024 shareholder-meetings Read more
2024 ESPI Report 64/2024

Management Board’s recommendation to pay a dividend for the 2023 financial year

23.12.2024 dividend Read more
2024 ESPI Report 63/2024

Appointment of the Management Board Members for another term of office

19.12.2024 other-issues Read more
2024 ESPI Report 62/2024

Information on the conclusion of a significant agreement on the sale of a robotic system

18.12.2024 da-vinci-en,sale-agreements Read more
2024 ESPI Report 61/2024

Information on the conclusion of a significant agreement on the sale of a robotic system

17.12.2024 da-vinci-en,sale-agreements Read more
2024 ESPI Report 60/2024

Modification of the date of publication of the standalone financial statements and the consolidated financial statements for the 2023 financial year

17.12.2024 other-issues Read more
2024 ESPI Report 59/2024

Selection of a Member to the Supervisory Board’s Nomination and Compensation Committee

26.11.2024 other-issues Read more
2024 ESPI Report 58/2024

Information on the conclusion of a significant agreement on the sale of a robotic system

08.11.2024 da-vinci-en,sale-agreements Read more
2024 ESPI Report 57/2024

Information on the conclusion of a significant agreement

07.11.2024 sale-agreements Read more
2024 ESPI Report 56/2024

Information on the conclusion of a significant sales agreement

05.11.2024 sale-agreements Read more
2024 ESPI Report 55/2024

Information on the conclusion of a significant agreement on the sale of a robotic system

04.11.2024 da-vinci-en,sale-agreements Read more
2024 ESPI Report 54/2024

Information on the conclusion of a significant agreement on the sale of a robotic system

28.10.2024 da-vinci-en,sale-agreements Read more
2024 ESPI Report 53/2024

Information on the conclusion of a significant agreement

24.10.2024 da-vinci-en,sale-agreements Read more
2024 ESPI Report 52/2024

Dates of publication of periodic reports

18.10.2024 other-issues,shareholder-meetings Read more
2024 ESPI Report 51/2024

Filling the vacancy on the Audit Committee and election of the Audit Committee Chairman

16.10.2024 other-issues Read more
2024 ESPI Report 50/2024

Operational highlights of the medical devices, IT solutions and services sales segment

11.10.2024 other-issues Read more
2024 ESPI Report 49/2024

Extension of the distribution agreement with Intuitive Surgical

10.10.2024 da-vinci-en,other-issues Read more
2024 ESPI Report 48/2024

Information on the conclusion of a significant sales agreement

09.10.2024 da-vinci-en,sale-agreements Read more
2024 ESPI Report 47/2024

List of shareholders with at least 5% of the total number of votes at the Extraordinary Shareholder Meeting held on 8 October 2024

09.10.2024 shareholder-meetings Read more
2024 ESPI Report 46/2024

Text of the resolutions adopted at the Extraordinary Shareholder Meeting of Synektik SA on 8 October 2024

08.10.2024 shareholder-meetings Read more
2024 ESPI Report 45/2024

Appointment of a Supervisory Board member

08.10.2024 other-issues,shareholder-meetings Read more
2024 ESPI Report 44/2024

Information on the conclusion of a significant agreement on the sale of a robotic system

08.10.2024 da-vinci-en,sale-agreements Read more
2024 ESPI Report 43/2024

Proposing a candidate to the Issuer’s Supervisory Board 

07.10.2024 other-issues,shareholder-meetings Read more
2024 ESPI Report 42/2024

Information on the conclusion of a significant agreement

03.10.2024 other-issues Read more
2024 ESPI Report 41/2024

Information on the conclusion of a significant agreement on the sale of a robotic system

25.09.2024 da-vinci-en,sale-agreements Read more
2024 ESPI Report 40/2024

Information on the conclusion of a significant agreement on the sale of a robotic system

24.09.2024 da-vinci-en,sale-agreements Read more
2024 ESPI Report 39/2024

Announcement on Convening an Extraordinary Shareholder Meeting to be held on 8 October 2024

10.09.2024 shareholder-meetings Read more
2024 ESPI Report 38/2024

Notification of transactions executed by a person discharging managerial responsibilities

06.09.2024 other-issues Read more
2024 ESPI Report 37/2024

Resignation of a Synektik SA Supervisory Board Member

02.09.2024 other-issues Read more
2024 ESPI Report 36/2024

Information on the conclusion of a significant sales agreement

22.08.2024 da-vinci-en,sale-agreements Read more
2024 ESPI Report 35/2024

Information on the conclusion of a significant agreement on the sale of a robotic system

20.08.2024 da-vinci-en,sale-agreements Read more
2024 ESPI Report 34/2024

Notification of transactions executed by a person discharging managerial responsibilities

14.08.2024 other-issues Read more
2024 ESPI Report 33/2024

Annex to the distribution agreement with Intuitive Surgical Sarl

01.08.2024 da-vinci-en,other-issues Read more
2024 ESPI Report 32/2024

Information on the conclusion of a significant agreement

26.07.2024 sale-agreements Read more
2024 ESPI Report 31/2024

Operational highlights of the medical devices, IT solutions and services sales segment

08.07.2024 other-issues Read more
2024 ESPI Report 30/2024

Information on the conclusion of a significant agreement on the sale of a robotic system

13.06.2024 da-vinci-en,sale-agreements Read more
2024 ESPI Report 29/2024

Information on the conclusion of a significant sales agreement

03.06.2024 da-vinci-en,sale-agreements Read more
2024 ESPI Report 28/2024

Information on the conclusion of a significant agreement

24.05.2024 da-vinci-en,sale-agreements Read more
2024 ESPI Report 27/2024

Partnership agreement for exclusive distribution of Symani microsurgery robots

22.05.2024 other-issues Read more
2024 ESPI Report 26/2024

Information on the conclusion of a significant agreement on the sale of a robotic system

17.05.2024 da-vinci-en,sale-agreements Read more
2024 ESPI Report 25/2024

Information on the conclusion of a significant agreement

06.05.2024 sale-agreements Read more
2024 ESPI Report 24/2024

Contract for the exclusive distribution of Qure.ai’s global artificial intelligence solution to assess the results of radiology tests in Poland, the Czech Republic and Slovakia

19.04.2024 other-issues Read more
2024 ESPI Report 23/2024

Information on the conclusion of a significant agreement on the sale of a robotic system

18.04.2024 da-vinci-en,sale-agreements Read more
2024 ESPI Report 22/2024

Operational highlights of the medical devices, IT solutions and services sales segment

10.04.2024 other-issues Read more
2024 ESPI Report 21/2024

Information on the conclusion of a significant agreement on the sale of a robotic system

09.04.2024 da-vinci-en,sale-agreements Read more
2024 ESPI Report 20/2024

Information on the conclusion of a significant sales agreement

28.03.2024 da-vinci-en,sale-agreements Read more
2024 ESPI Report 19/2024

Notification of transactions executed by a person discharging managerial responsibilities

12.03.2024 other-issues Read more
2024 ESPI Report 18/2024

Information on the conclusion of a significant sales agreement

08.03.2024 da-vinci-en,sale-agreements Read more
2024 ESPI Report 17/2024

List of shareholders holding at least 5% of the total number of votes at the Ordinary Shareholder Meeting on 26 February 2024

27.02.2024 shareholder-meetings Read more
2024 ESPI Report 16/2024

Resolutions adopted by the Ordinary Shareholder Meeting of Synektik SA on 26 February 2024

27.02.2024 shareholder-meetings Read more
2024 ESPI Report 15/2024

Dividend payout resolution

26.02.2024 dividend,shareholder-meetings Read more
2024 ESPI Report 14/2024

Information on the conclusion of a significant agreement on the sale of a robotic system

26.02.2024 da-vinci-en,sale-agreements Read more
2024 ESPI Report 13/2024

Notification of transactions executed by a person discharging managerial responsibilities

23.02.2024 other-issues Read more
2024 ESPI Report 12/2024

Information on the conclusion of a significant sales agreement

22.02.2024 da-vinci-en,sale-agreements Read more
2024 ESPI Report 11/2024

Expansion of a cooperation agreement

22.02.2024 other-issues Read more
2024 ESPI Report 10/2024

Notification of transactions executed by a person discharging managerial responsibilities

21.02.2024 other-issues Read more
2024 ESPI Report 9/2024

Information on the conclusion of a significant agreement on the sale of a robotic system

19.02.2024 da-vinci-en,sale-agreements Read more
2024 ESPI Report 8/2024

Estimated revenue in Q1 2023

31.01.2024 other-issues Read more
2024 ESPI Report 7/2024

Obtaining a patent for a cardiac marker in Japan

25.01.2024 cardiotracer Read more
2024 Appendix 2 – ESPI Report 6/2024

Auditor's assessment of Synektik's report on payments of the Management Board and Supervisory Board for FY2022

25.01.2024 shareholder-meetings Read more
2024 Appendix 1 – ESPI Report 6/2024

Report on payments of the Management Board and Supervisory Board for FY2022

25.01.2024 shareholder-meetings Read more
2024 ESPI Report 6/2024

Completion of documentation to be discussed at the Ordinary General Meeting of SYNEKTIK SA

25.01.2024 shareholder-meetings Read more
2024 Appendix – ESPI Report 5/2024/K

Corrected draft resolutions attached to ESPI report 5/2024/K

22.01.2024 shareholder-meetings Read more
2024 ESPI Report 5/2024/K

Correction of current report ESPI 5/2024 - Announcement on convening the Ordinary General Meeting of Shareholders for February 26, 2024


22.01.2024 shareholder-meetings Read more
2024 Appendixes – ESPI Report 5/2024 22.01.2024 shareholder-meetings Read more
2024 ESPI Report 5/2024

Announcement on the convening of the Ordinary General Meeting of Shareholders for February 26, 2024

22.01.2024 shareholder-meetings Read more
2024 ESPI Report 4/2024

Recommendation of the Management Board on the payment of dividends for FY2022

19.01.2024 dividend Read more
2024 ESPI Report 3/2024

Establishment of a bank guarantee for a counterparty

17.01.2024 other-issues Read more
2024 ESPI Report 2/2024

Update on the cardiotracer project

10.01.2024 cardiotracer Read more
2024 ESPI Report 1/2024

Selected operating data of the medical devices, IT solutions and services sales segment

08.01.2024 other-issues Read more